Abstract
We conducted clinicopathologic and immunohistochemical analyses of the prevalence of Epstein-Barr virus (EBV) among 24 patients with malignant lymphoma complicating systemic rheumatic diseases. (SRD) These 24 patients included 17 with rheumatoid arthritis (RA), 3 with systemic lupus erythematosus (SLE), 2 with systemic sclerosis (SS), and 2 with dermatomyositis (DM). There were 2 men and 22 women ranging in age from 30 to 86 years (mean: 64 years). The interval between the onset of rheumatic disease and that of malignant lymphomas ranged from 3 months to 35 years (mean: 142 months). The use of immunosuppressive drugs before the onset of malignant lymphoma was recorded in 15 patients. Among them, 5 patients received methotrexate (MTX) therapy. Malignant lymphomas were found at extranodal sites in 9 patients, and the disease was in the advanced stage in 17 patients. Histologic and immunohistochemical studies demonstrated that 18 cases (75%) were B-cell lymphoma (RA=12, SLE=2, SS=2, DM=2), 3 (12.5%) were peripheral T-cell lymphoma (RA=3), and 3 (12.5%) were classical Hodgkin lymphoma (RA=2, SLE=1). As in previous reports, there was an increased frequency of diffuse large B-cell lymphoma (50%) in the present series. Moreover, a maj...Continue Reading
References
Oct 7, 1978·Lancet·J A GreenW Walker
Jan 1, 1978·Journal of Chronic Diseases·H A IsomäkiU Joutsenlahti
Jan 1, 1977·British Journal of Cancer·R PetoP G Smith
Feb 13, 1975·The New England Journal of Medicine·A Bohan, J B Peter
May 1, 1988·Arthritis and Rheumatism·M DauphinéeN Talal
Mar 1, 1988·Arthritis and Rheumatism·F C ArnettH S Luthra
Sep 1, 1985·Arthritis and Rheumatism·C Plater-ZyberkG Janossy
Apr 1, 1984·Annals of the Rheumatic Diseases·D P SymmonsD L Scott
May 1, 1980·Arthritis and Rheumatism
Jan 1, 1981·Bulletin on the Rheumatic Diseases
Jul 1, 1994·Human Pathology·G Frizzera
Jul 1, 1994·Human Pathology·O W KamelR F Dorfman
Oct 1, 1996·The American Journal of Surgical Pathology·O W KamelE S Jaffe
Apr 1, 1997·Japanese Journal of Clinical Oncology·M KojimaT Suchi
Sep 30, 2000·Pathology International
Oct 2, 2001·Scandinavian Journal of Rheumatology·M J Leandro, D A Isenberg
Jun 10, 2003·Arthritis and Rheumatism·Eva BaecklundLars Klareskog
Sep 25, 2003·Blood·Christine P HansWing C Chan
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Yoshihiko HoshidaKatsuyuki Aozasa
Aug 9, 2005·International Journal of Surgical Pathology·Masaru KojimaShigeo Nakamura
Citations
May 27, 2008·Clinical Rheumatology·Eva SzekaneczGabriella Szucs
Oct 8, 2009·Clinical Rheumatology·Serena VettoriGabriele Valentini
May 4, 2010·Modern Rheumatology·Saori HatachiMasato Yagita
May 28, 2009·International Journal of Hematology·Timucin CilSabri Batun
Nov 13, 2009·Journal of Clinical and Experimental Hematopathology : JCEH·Masaru KojimaHiroshi Inagaki
Dec 3, 2010·Journal of Clinical and Experimental Hematopathology : JCEH·Masaru KojimaShigeo Nakamura
Jan 11, 2013·Annals of the Rheumatic Diseases·Sasha BernatskyAnn E Clarke
Oct 13, 2006·Kidney International·S H NasrG S Markowitz
Mar 14, 2012·Autoimmunity Reviews·Éva SzekaneczZoltán Szekanecz
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·Sasha BernatskyAnn E Clarke
Feb 6, 2009·Annales de chirurgie plastique et esthétique·G DrossardV Darsonval
Oct 27, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·M KojimaS Nakamura
Jul 25, 2006·Pathology, Research and Practice·Masaru KojimaShigeo Nakamura
Jan 15, 2015·Immunologic Research·Dana Butnaru, Yehuda Shoenfeld
Feb 27, 2020·International Journal of Rheumatic Diseases·Vadim Romanovich GorodetskiyVladimir Ivanovich Vasilyev